Effect of voluntary licences for hepatitis C medicines on access to treatment: a difference-in-differences analysis

Summary: Background: Voluntary licences are increasingly being used to expand access to patented essential medicines in low-income and middle-income countries (LMICs). Since 2014, non-exclusive voluntary licences have been issued by Gilead and Bristol-Myers Squibb for key drugs for hepatitis C virus...

Full description

Saved in:
Bibliographic Details
Main Authors: Bryony Simmons, MPH (Author), Graham S Cooke, ProfFRCP (Author), Marisa Miraldo, PhD (Author)
Format: Book
Published: Elsevier, 2019-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available